Sarah Cannon Cancer Institute
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Sarah Cannon Cancer Institute
Jun 15, 2024, 15:32 |
Blog
Yüksel Ürün: As a GU oncologist my non-GU key highlights from ASCO24
Yüksel Ürün shared on X/Twitter: "As a GU oncologist my non-GU key highlights from ASCO24. 1.…
Apr 10, 2024, 08:53 |
Insight
Vivek Subbiah: Cell atlas projects have contributed to our understanding of cancers
Vivek Subbiah shared on X/Twitter: "We have learned a lot from cell atlas projects -…
Apr 10, 2024, 08:31 |
Blog
Vivek Subbiah: Congratulations to all the AACR fellows 2024
Vivek Subbiah recently shared on his X/Twitter: ''Congratulations to all the AACR fellows at AACR24!…
Apr 8, 2024, 16:49 |
Blog
Vivek Subbiah: News article on the AACR Plenary Session 2024
Vivek Subbiah shared on LinkedIn: "News article on the AACR Plenary Session 2024 'AI at…
Mar 10, 2024, 12:17 |
Blog
Amy Ware: I've been particularly impressed by people I've met and partnered with since joining HCA Healthcare | TriStar Division and Sarah Cannon Cancer Institute
Amy Ware, Associate Regional Vice President of Oncology at HCA Healthcare, shared on LinkedIn: “I've…
Mar 2, 2024, 19:08 |
Blog
Vanessa Hoffmann: Sarah Cannon has an opportunity to join our Amazing Team!
Vanessa Hoffmann, Immediate Past President of the National Cancer Registrars Association, shared a post on…
Feb 22, 2024, 10:54 |
Career
Navneet Majhail: We are hiring transplant and cellular therapy physicians, nurses, APPs, PharmDs at our growing HCA Healthcare Sarah Cannon Cancer Institute
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon Cancer Institute, recently posted on LinkedIn:…
All:
7
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube